AVITA Medical, Inc. (RCEL)
16.20
-1.10
(-6.36%)
USD |
NASDAQ |
Nov 12, 16:00
16.16
-0.04
(-0.25%)
After-Hours: 20:00
AVITA Medical Free Cash Flow (Quarterly) : -0.7296M for Sept. 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.7296M |
| June 30, 2026 | -3.742M |
| March 31, 2026 | -10.09M |
| December 31, 2025 | -4.850M |
| September 30, 2025 | -6.520M |
| June 30, 2025 | -10.97M |
| March 31, 2025 | -10.54M |
| December 31, 2024 | -8.502M |
| September 30, 2024 | -11.51M |
| June 30, 2024 | -15.48M |
| March 31, 2024 | -22.09M |
| December 31, 2023 | -11.01M |
| Date | Value |
|---|---|
| September 30, 2023 | -9.088M |
| June 30, 2023 | -9.193M |
| March 31, 2023 | -9.374M |
| December 31, 2022 | -3.050M |
| September 30, 2022 | -2.450M |
| June 30, 2022 | -3.640M |
| March 31, 2022 | -9.446M |
| June 30, 2021 | -3.797M |
| March 31, 2021 | -9.982M |
| December 31, 2020 | -6.170M |
| September 30, 2020 | -8.009M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Iovance Biotherapeutics, Inc. | -9.306M |
| Halozyme Therapeutics, Inc. | 255.22M |
| Agenus, Inc. | -20.10M |
| Amgen, Inc. | 3.654B |
| Fate Therapeutics, Inc. | -27.89M |